Gene therapy for inherited retinal diseases
At a glance
- Founded: 2019
- HQ: Durham
- Sector: Biotech
- Stage: Series C
- Total raised: $213.2M
- Last round: Series C
See the full company record.
Founders, funding history and recent signals. Free accounts open immediately.
Listed roles
All Triangle rolesChecking listed roles…